Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol.
Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol. Blood Adv. 2024 Jun 25; 8(12):3001-3012.
View in:
PubMed
subject areas
Adult
Aged
Epstein-Barr Virus Infections
Female
Hematopoietic Stem Cell Transplantation
Herpesvirus 4, Human
Humans
Lymphoproliferative Disorders
Male
Middle Aged
Organ Transplantation
Transplantation, Homologous
Treatment Outcome
Young Adult
authors with profiles
Koen Van Besien